NCT03715933 2026-05-22Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasInhibrx Biosciences, IncPhase 1 Recruiting411 enrolled
NCT06794645 2025-01-27Pembrolizumab and Pemetrexed for Progressive ChordomaSaint John's Cancer InstitutePhase 2 Recruiting21 enrolled